On Innovative Activity in Pharmaceutical Industry
https://doi.org/10.34020/2073-6495-2021-2-168-174
Abstract
The article provides with different approaches to the assessment of pharmaceutical manufacturers’ innovation activity. The peculiarities of pharmaceutical industry product that can be characterized as innovative are taken into consideration. Special attention has been given to the pharmaceutical industry peculiarities originating from differentiation of original drug products and generics in the structure of pharmaceutical industry production. Based on these findings the classification of Russian pharmaceutical manufacturers in accordance with their innovation activity extent evaluated by their activity in clinical trials conducting was developed. The classification is based upon k-means clustering algorithm with 5 clusters specified.The small amount of manufacturers involved in clinical trials conducting and some optimistic insights about the original products share were concluded hereafter.
About the Authors
M. I. Berkovich
Kostroma State University
Russian Federation
Russian Federation
Berkovich Margarita I., Doctor of Economics, Professor, Director, Institute of Economics, Management and Finance
Kostroma
A. Yu. Volin
Kostroma State University
Russian Federation
Russian Federation
Volin Andrey Yu., Postgraduate Student, Department of Economics and Management
Kostroma
References
1. Vertakova Ju.V., Simonenko E.S. Upravlenie innovacijami: teorija i praktika: ucheb. posobie. M.: Jeksmo, 2008. 432 p.
2. Gunin V.N., Barancheev V.P., Ustinov V.A., Ljapina S.Ju. Upravlenie innovacijami: 17-modul’naja programma dlja menedzherov «Upravlenie razvitiem organizacii». Modul’ 7. M.: INFRA-M, 2000. 328 p.
3. Zabolotskij S.A., Markov L.S. Innovacionnaja aktivnost’ predprijatij otechestvennoj himicheskoj promyshlennosti // JeKO. 2010. № 3 (429). P. 64–75.
4. Mysachenko V.I. Sovershenstvovanie gosudarstvennogo regulirovanija innovacionnoj dejatel’nosti farmacevticheskih predprijatij // Znanie. Ponimanie. Umenie. 2019. № 4. P. 56–60.
5. Ob utverzhdenii otraslevogo plana meroprijatij po importozameshheniju v otrasli farmacevticheskoj promyshlennosti Rossijskoj Federacii: Prikaz Ministerstva promyshlennosti i torgovli ot 31 marta 2015 g. № 656.
6. Ob utverzhdenii Strategii razvitija farmacevticheskoj promyshlennosti Rossijskoj Federacii na period do 2020 goda: Prikaz Ministerstva promyshlennosti i torgovli RF ot 23 oktjabrja 2009 g. № 965.
7. Fathutdinov R.A. Innovacionnyj menedzhment: Uchebnik dlja vuzov. SPb.: Piter, 2011. 448 p.
8. DiMasi J.A., Grabowski H.G., Hansen R.W. Innovation in the pharmaceutical industry: New estimates of R&D costs // Journal of Health Economics. 2016. № 47. P. 20–33.
9. Edwards L.D., Fletcher A.J., Fox A.W., Stonier P.D. Principals and practice of pharmaceutical medicine. Second edition. Chichester, Velikobritanija: John Wiley & Sons Ltd, 2007. 761 p.
10. General considerations for clinical studies:Rukovodstvo Mezhdunarodnoj konferencii po garmonizacii tehnicheskih trebovanij k registracii lekarstvennyh preparatov dlja cheloveka (ICH) ot 08 maja 2019 g. № E8 (R1).
11. Rogers M. The Definition and Measurement of Innovation. [Jelektronnyj resurs] // Melbourne Institute Working Paper No. 10/98. Mel’burn, Avstralija:The University of Melbourne, 1998. 27 p.
12. Innovacija. [Jelektronnyj resurs] // Bol’shaja rossijskaja jenciklopedija. URL: https://bigenc.ru/economics/text/2012242 (data obrashhenija: 20.09.2020).
13. Gosudarstvennyj reestr lekarstvennyh sredstv. [Jelektronnyj resurs]. URL: https://grls.rosminzdrav.ru/GRLS.aspx (data obrashhenija: 29.10.2020).
14. Analiticheskaja spravka o sostojanii konkurencii na mirovom farmacevticheskom rynke. [Jelektronnyj resurs] / Federal’naja Antimonopol’naja Sluzhba (FAS Rossii), 2016. URL: https://fas.gov.ru/p/presentations/317 (data obrashhenija: 04.11.2020).
Review
For citations:
Berkovich M.I., Volin A.Yu. On Innovative Activity in Pharmaceutical Industry. Vestnik NSUEM. 2021;(2):168-174. (In Russ.) https://doi.org/10.34020/2073-6495-2021-2-168-174
Email this article 
